These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3995506)

  • 1. Mutagenicity and tumor initiating activity of methylated benzo[k] fluoranthenes.
    Amin S; Hussain N; Balanikas G; Huie K; Hecht SS
    Cancer Lett; 1985 Apr; 26(3):343-7. PubMed ID: 3995506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity and tumor initiating activity of methylated benzo[b]fluoranthenes.
    Amin S; Huie K; Hecht SS
    Carcinogenesis; 1985 Jul; 6(7):1023-5. PubMed ID: 3893781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour initiating activity of dihydrodiols of benzo[b]fluoranthene, benzo[j]fluoranthene, and benzo[k]fluoranthene.
    LaVoie EJ; Amin S; Hecht SS; Furuya K; Hoffmann D
    Carcinogenesis; 1982; 3(1):49-52. PubMed ID: 7067037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mutagenicity and tumor-initiating activity of methylated fluorenes.
    Lavoie EJ; Coleman DT; Geddie NG; Rice JE
    Chem Biol Interact; 1985 Jan; 52(3):301-9. PubMed ID: 3882256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fluorine substitution on benzo[j]fluoranthene genotoxicity.
    Weyand EH; He ZM; Ghodrati F; Wu Y; Marshall MV; LaVoie EJ
    Chem Biol Interact; 1992 Sep; 84(1):37-53. PubMed ID: 1394615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
    Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-initiating activity, mutagenicity, and metabolism of methylated anthracenes.
    La Voie EJ; Coleman DT; Rice JE; Geddie NG; Hoffmann D
    Carcinogenesis; 1985 Oct; 6(10):1483-8. PubMed ID: 3899400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mutagenic dihydrodiols as metabolites of benzo(j)fluoranthene and benzo(k)fluoranthene.
    LaVoie EJ; Hecht SS; Amin S; Bedenko V; Hoffmann D
    Cancer Res; 1980 Dec; 40(12):4528-32. PubMed ID: 7002294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked differences between mutagenicity in Salmonella and tumour-initiating activities of dibenzo[a,e]fluoranthene proximate metabolites; initiation inhibiting activity of norharman.
    Zajdela F; Perin-Roussel O; Saguem S
    Carcinogenesis; 1987 Mar; 8(3):461-4. PubMed ID: 3545527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative tumor initiating activity of benzo[a]fluoranthene, benzo[b]fluoranthene, naphtho[1,2-b]fluoranthene and naphtho[2,1-a]fluoranthene on mouse skin.
    Weyand EH; Patel S; LaVoie EJ; Cho B; Harvey RG
    Cancer Lett; 1990 Jul; 52(3):229-33. PubMed ID: 2379145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the tumor-initiating activity of 4-, 5-, 6-, and 7-fluorobenzo[b]fluoranthene in mouse skin.
    LaVoie EJ; Cai ZW; Meegalla RL; Weyand EH
    Chem Biol Interact; 1993 Dec; 89(2-3):129-39. PubMed ID: 8269542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of methylated fluorenes and benzofluorenes.
    Lavoie EJ; Tulley L; Bedenko V; Hoffmann D
    Mutat Res; 1981 May; 91(3):167-76. PubMed ID: 7017394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and mutagenic activity of benzo[k]fluoranthene and 3-, 8- and 9-fluorobenzo[k]fluoranthene.
    Weyand EH; Geddie N; Rice JE; Czech A; Amin S; LaVoie EJ
    Carcinogenesis; 1988 Jul; 9(7):1277-81. PubMed ID: 3383345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of a vicinal, non-bay-region dihydrodiol-epoxide in the activation of dibenzo[a,e]fluoranthene into bacterial mutagens.
    Malaveille C; Hautefeuille A; Perin-Roussel O; Saguem S; Croisy-Delcey M; Zajdela F; Bartsch H
    Carcinogenesis; 1984 Oct; 5(10):1263-6. PubMed ID: 6386214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and tumor-initiating activities of dimethylchrysenes.
    Amin S; Balanikas G; Huie K; Hecht SS
    Chem Res Toxicol; 1988; 1(6):349-55. PubMed ID: 2979752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the mutagenic metabolites of fluoranthene, 2-methylfluoranthene, and 3-methylfluoranthene.
    LaVoie EJ; Hecht SS; Bedenko V; Hoffmann D
    Carcinogenesis; 1982; 3(8):841-6. PubMed ID: 7127666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenic activity of non-alternant polynuclear aromatic hydrocarbons in newborn mice.
    Lavoie EJ; Braley J; Rice JE; Rivenson A
    Cancer Lett; 1987 Jan; 34(1):15-20. PubMed ID: 3802065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity, tumor-initiating activity, and metabolism of methylphenanthrenes.
    LaVoie EJ; Tulley-Freiler L; Bedenko V; Hoffman D
    Cancer Res; 1981 Sep; 41(9 Pt 1):3441-7. PubMed ID: 7020927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenicity and mutagenicity of some alkoxy cyclopenta[a]phenanthren-17-ones; effect of obstructing the bay region.
    Bhatt TS; Hadfield ST; Coombs MM
    Carcinogenesis; 1982; 3(6):677-80. PubMed ID: 7116562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.